MDXG: Undisclosed Adverse Reaction Contradicts Product Safety Claims - Aurelius Value
MiMedx boldly claims on its website that it has “distributed more than 1 million allografts to date with zero reported adverse reactions attributed to our products”. Yet, according to a lawsuit filed earlier this month, an Epifix patient suffered an adverse reaction so severe that she was left permanently maimed.